Biocon Biologics grants Sandoz exclusive rights to market biosimilar adalimumab in Japan
Adalimumab BS for subcutaneous injection is indicated for immune-related diseases such as rheumatoid arthritis, psoriasis vulgaris, ankylosing spondylitis, Crohn's disease, and ulcerative colitis. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 22, 2023 Category: Pharmaceuticals Source Type: news
FDA grants priority review to Xolair (omalizumab) for children and adults with food allergies based on positive National Institutes of Health phase III study results
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposureInterim analysis results from first-of-its-kind phase III OUtMATCH study showed Xolair significantly increased the amount of peanut, milk, egg and cashew it took to cause an allergic reaction17 million people in the U.S. have confirmed food allergies and more than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2,3Basel, 19 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration ...
Source: Roche Media News - December 19, 2023 Category: Pharmaceuticals Source Type: news
FDA grants priority review to Xolair (omalizumab) for children and adults with food allergies based on positive National Institutes of Health phase III study results
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposureInterim analysis results from first-of-its-kind phase III OUtMATCH study showed Xolair significantly increased the amount of peanut, milk, egg and cashew it took to cause an allergic reaction17 million people in the U.S. have confirmed food allergies and more than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2,3Basel, 19 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration ...
Source: Roche Investor Update - December 19, 2023 Category: Pharmaceuticals Source Type: news
Novel Oral Agent May Dial Down Ulcerative Colitis Severity
(MedPage Today) -- ORLANDO -- For patients diagnosed with moderate to severe ulcerative colitis, the investigational agent icanbelimod had mixed results in reducing the severity of disease within 12 weeks when used as induction and maintenance... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - December 19, 2023 Category: Gastroenterology Source Type: news
6 Myths About IBD, Debunked
Michelle Pickens’ symptoms escalated in college. At the time, she was throwing up at least once a day, and experiencing frequent nausea, abdominal pain, diarrhea, and constipation. Juggling classes with work at a design studio became an extreme exercise in perseverance. She knew in her gut that something was wrong.
Yet three different doctors “wrote it off as stress,” says Pickens, now 32, who lives in Annapolis, Md. Lab work and procedures to see inside her gastrointestinal tract showed nothing abnormal. “No one wanted to dig deeper,” she recalls. In a final act of desperation, Pickens sa...
Source: TIME: Health - December 18, 2023 Category: Consumer Health News Authors: Lindsay Lyon Tags: Uncategorized healthscienceclimate Source Type: news
PSMA-PET shows promise in patients with IBD
This study demonstrates that PSMA-targeted F-18 DCFPyL PET can effectively detect regions of inflamed mucosa in patients with IBD, suggesting its utility as a noninvasive imaging agent to assess location, extent, and disease activity,” the group concluded.The full study is available here. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 18, 2023 Category: Radiology Authors: Will Morton Tags: Gastrointestinal Radiology Source Type: news
Goodbye, Appendix. Hello, Crohn's Disease?
(MedPage Today) -- ORLANDO – People who undergo appendectomy may have an increased risk for the development of Crohn's disease (CD), but not ulcerative colitis (UC), according to a systematic review and meta-analysis.
The meta-analysis showed... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - December 17, 2023 Category: Gastroenterology Source Type: news
Red Meat Consumption Tied to Higher Chance of UC Flare
(MedPage Today) -- ORLANDO – For people with inflammatory bowel disease (IBD), that hamburger may come with more than just a side of fries -- red meat consumption was linked with a higher risk for ulcerative colitis (UC) flare, researchers... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - December 17, 2023 Category: Gastroenterology Source Type: news
Changes in Biochemical, Hematological Parameters Seen Before IBD Diagnosis
MONDAY, Dec. 11, 2023 -- Changes in multiple biochemical and hematological parameters occur up to eight years before diagnosis of Crohn disease and up to three years before diagnosis of ulcerative colitis, according to a study published in the Nov.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 11, 2023 Category: Pharmaceuticals Source Type: news
Consumer Health: Do you know the signs of inflammatory bowel disease?
Crohn ’s and Colitis Awareness Week will be observed Dec. 1 –7, which makes this a good time to learn about the signs and symptoms of these disorders. Researchers estimate that more than half a million people in the U.S. have Crohn ’s disease, and 600,000 to 900,000 people in the U.S. have ulcerative colitis, according to the National Institute of Diabetes and Digestive and Kidney Diseases. Inflammatory bowel disease is an umbrella term used to describe disorders that involve chronic inflammation of your… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 1, 2023 Category: Databases & Libraries Source Type: news
New Guselkumab Responses in Ulcerative Colitis Emerge After 12 Weeks
(MedPage Today) -- In a previous video, investigator Jessica Allegretti, MD, of the Crohn's and Colitis Center at Brigham and Women's Hospital in Boston, discussed the results from the QUASAR phase III induction study presented at the American... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - November 15, 2023 Category: Gastroenterology Source Type: news
Home-made FECAL transplants from my husband cured my ulcerative colitis - after 15 years of pain
Saffron Cassaday (pictured), 36, had been living with the type of inflammatory bowel disease (IBD), an autoimmune condition where the immune system attacks the colon. (Source: the Mail online | Health)
Source: the Mail online | Health - November 14, 2023 Category: Consumer Health News Source Type: news
Crohn ’s disease can be detected in blood eight years before symptoms show, finds study
Findings may enable earlier treatment before severe damage happens requiring life-changing surgerySigns of the debilitating bowel condition Crohn ’s disease can be detected in routine blood tests up to eight years before the onset of symptoms, and up to three years before a diagnosis of ulcerative colitis. The discovery suggests that early stages of inflammatory bowel diseases may begin far earlier than previously assumed, and may eventuall y enable doctors to intervene before severe damage occurs.Crohn ’s disease and ulcerative colitis are inflammatory bowel diseases (IBD) that affect more than 500,000 people in the U...
Source: Guardian Unlimited Science - November 7, 2023 Category: Science Authors: Linda Geddes Science correspondent Tags: Health Medical research Science Source Type: news
Blood tests offer hope for early diagnosis of Crohn's disease, ulcerative colitis
Blood tests can reliably detect warning signs of inflammatory bowel disease much earlier than previously thought, paving the way for preventative or prophylactic action to be taken before the illness progresses. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 7, 2023 Category: Consumer Health News Source Type: news
Mayo Clinic Q and A: Treatment for a parastomal hernia
DEAR MAYO CLINIC: My friend had a stoma created after years of managing Crohn's disease. She recently had surgery to repair a hernia. What is a stoma, and are these types of hernias common? What is the typical treatment? ANSWER: Occasionally, the surgical treatment of Crohn's disease, ulcerative colitis and other gastrointestinal, gynecologic, or urologic conditions, both cancerous or benign, may require reconstruction or removal of the bladder, colon, or rectum. Surgeons may use other… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 7, 2023 Category: Databases & Libraries Source Type: news
